HUP0303638A3 - Method for producing a vaccine - Google Patents

Method for producing a vaccine

Info

Publication number
HUP0303638A3
HUP0303638A3 HU0303638A HUP0303638A HUP0303638A3 HU P0303638 A3 HUP0303638 A3 HU P0303638A3 HU 0303638 A HU0303638 A HU 0303638A HU P0303638 A HUP0303638 A HU P0303638A HU P0303638 A3 HUP0303638 A3 HU P0303638A3
Authority
HU
Hungary
Prior art keywords
vaccine
producing
Prior art date
Application number
HU0303638A
Other languages
English (en)
Original Assignee
Igeneon Krebs Immuntherapie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs Immuntherapie filed Critical Igeneon Krebs Immuntherapie
Publication of HUP0303638A2 publication Critical patent/HUP0303638A2/hu
Publication of HUP0303638A3 publication Critical patent/HUP0303638A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU0303638A 2001-03-23 2002-03-20 Method for producing a vaccine HUP0303638A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0047001A AT410636B (de) 2001-03-23 2001-03-23 Verfahren zur herstellung eines impfstoffes
PCT/AT2002/000091 WO2002080966A2 (de) 2001-03-23 2002-03-20 Verfahren zur herstellung eines autologen antikörpers enthaltenden impfstoffes

Publications (2)

Publication Number Publication Date
HUP0303638A2 HUP0303638A2 (hu) 2004-01-28
HUP0303638A3 true HUP0303638A3 (en) 2004-10-28

Family

ID=3674741

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303638A HUP0303638A3 (en) 2001-03-23 2002-03-20 Method for producing a vaccine

Country Status (13)

Country Link
US (1) US20040191242A1 (hu)
EP (1) EP1370289A2 (hu)
JP (1) JP2004524369A (hu)
CN (1) CN1522155A (hu)
AT (1) AT410636B (hu)
BR (1) BR0208641A (hu)
CA (1) CA2441499A1 (hu)
HU (1) HUP0303638A3 (hu)
MX (1) MXPA03008587A (hu)
NO (1) NO20034145L (hu)
PL (1) PL363720A1 (hu)
SK (1) SK11732003A3 (hu)
WO (1) WO2002080966A2 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT410637B (de) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie Verwendung von polyklonalen immunglobulinen
WO2005090403A2 (en) * 2004-03-12 2005-09-29 Biovest International, Inc. Method and apparatus for antibody purification
JP5415963B2 (ja) * 2007-02-21 2014-02-12 オスロ ユニベルシテートシケヒュース ホーエフ 新しい癌マーカー
EP2236520A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Stabilizing composition for immobilized biomolecules
WO2022103871A1 (en) * 2020-11-10 2022-05-19 Wyomingv Immune, Inc. Therapeutic compositions for the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4436558A1 (de) * 1994-10-13 1996-04-18 Vitorgan Arzneimittel Gmbh Verfahren zur Herstellung von humanen Impfstoffen gegen allergieauslösende Substanzen
EP0792294A1 (en) * 1994-11-16 1997-09-03 Baxter International Inc. Human antibodies to t-cell receptor peptides and methods for their preparation
DE19538641C2 (de) * 1995-10-05 2000-09-21 Privates Inst Bioserv Gmbh Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung
WO1998026086A1 (en) * 1996-12-11 1998-06-18 University Of Florida Novel methods and compositions for treatment of autoimmune diseases
US7022036B2 (en) * 2003-05-21 2006-04-04 Prototoy Llc Electronic throw-and-catch game

Also Published As

Publication number Publication date
NO20034145L (no) 2003-11-07
AT410636B (de) 2003-06-25
BR0208641A (pt) 2004-03-09
WO2002080966A2 (de) 2002-10-17
PL363720A1 (en) 2004-11-29
HUP0303638A2 (hu) 2004-01-28
CN1522155A (zh) 2004-08-18
SK11732003A3 (sk) 2004-03-02
ATA4702001A (de) 2002-11-15
CA2441499A1 (en) 2002-10-17
JP2004524369A (ja) 2004-08-12
WO2002080966A3 (de) 2003-09-12
MXPA03008587A (es) 2004-06-30
WO2002080966A8 (de) 2003-01-23
NO20034145D0 (no) 2003-09-17
US20040191242A1 (en) 2004-09-30
EP1370289A2 (de) 2003-12-17

Similar Documents

Publication Publication Date Title
GB2420808B (en) Method for forming a monodiameter wellbore
SG121719A1 (en) Method for creating a workflow
EP1437327A4 (en) PROCESS FOR PREPARING SILICON
IL194034A (en) Method for preparing o-desmethylvenlafaxine
TWI318623B (en) Process for producing bisphenol a
GB2372575B (en) Method for forming a sachet
EP1350781A4 (en) PROCESS FOR PRODUCING BISPHENOL A
PL361146A1 (en) Method for producing isocyanato-organosilanes
GB0221060D0 (en) Method for producing a fluoropolymer
HUP0102967A3 (en) Method for producing organosilylalkyl-polysulphanes
EP1273563A4 (en) PROCESS FOR PRODUCING BISPHENOL A
GB2382224B (en) Method for producing a substrate arrangement
GB0107562D0 (en) Method for forming a body
EP1367043A4 (en) PROCESS FOR PRODUCING BISPHENOL A
IL159072A0 (en) Method for producing n-phosphonomethylglycine
HUP0303638A3 (en) Method for producing a vaccine
IL160818A0 (en) Method for producing 3-bromomethylbenzoic acids
IL154825A0 (en) A METHOD FOR PRODUCING Delta1-PYRROLINES
PL363281A1 (en) Method for producing 2-[-5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane
HUP0104629A3 (en) Method for producing cyclopropanecarboxylates
IL159492A (en) Method for producing n-phosphonomethylglycine
AU7265900A (en) Method for producing otoplastics
EP1352887A4 (en) PROCESS FOR PRODUCING BISPHENOL A
EP1457568A4 (en) PROCESS FOR PRODUCING 2'-DESOXYGUANOSINE
IL158495A0 (en) A two-step method for producing paclitaxel

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees